Atlas Trials

Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant

Clinical trial NCT03068819 · COMPLETED

Trial details

NCT number
NCT03068819
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2017-10-23
Primary completion
2025-06-15
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.